Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

December 31, 2010

Conditions
Lung Cancer
Interventions
OTHER

Nutritional Assessment

Patients will receive nutritional assessment one week prior to treatment until completing two courses of chemotherapy

DIETARY_SUPPLEMENT

EPA-DHA arm

Patients will be randomized to receive two cans/day of EPA and DHA containing oral supplement one week prior to treatment until completing two courses of chemotherapy

Trial Locations (2)

14080

RECRUITING

National Institute of Cancerologia, Mexico City

RECRUITING

National Institute of Cancerología, Mexico City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

National Institute of Cancerología

OTHER_GOV